Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025

Rhea-AI Summary

Haemonetics (NYSE: HAE) will publish Q2 fiscal 2026 results at 6:00 AM ET on Thursday, November 6, 2025. The company will host a conference call with investors and analysts at 8:00 AM ET on November 6, 2025 to discuss results and answer questions.

Participants must register for teleconference access and will receive a dial-in number and personalized PIN; joining 10 minutes early is recommended. A live webcast will be available on Haemonetics' investor relations website at the provided webcast link. A replay of the call and webcast will be available for one year beginning November 6, 2025 at 11:00 AM ET.

News Market Reaction

-2.59%

1 alert

-2.59% News Effect

On the day this news was published, HAE declined 2.59%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, Oct. 9, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2026 financial results at 6:00 am ET on Thursday, November 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on November 6, 2025.

The call can be accessed via teleconference at: Q2 2026 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/6q36mw7d

A replay of the conference call and webcast will be available for one year beginning on November 6, 2025 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com	david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2026-results-november-6-2025-302580124.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics (HAE) release Q2 fiscal 2026 results?

Haemonetics will publish Q2 fiscal 2026 results at 6:00 AM ET on November 6, 2025.

What time is the Haemonetics (HAE) earnings call for Q2 2026?

The earnings conference call is scheduled for 8:00 AM ET on November 6, 2025.

How can investors join the Haemonetics (HAE) Q2 2026 conference call?

Investors can register for the teleconference to receive a dial-in number and personalized PIN or listen via the live webcast on Haemonetics' investor relations website.

Where can I find the Haemonetics (HAE) live webcast link for the Q2 2026 call?

The live webcast is available via the company's investor relations site using the provided webcast link; registration details are on the site.

Will there be a replay of the Haemonetics (HAE) Q2 2026 earnings call?

Yes. A replay of the conference call and webcast will be available for one year starting November 6, 2025 at 11:00 AM ET.